About the Department
The Department of Pharmacology at School of Pharmaceutical Education and Research (SPER), Jamia Hamdard was established in the year 1975. The primary goal of the department is to train the students preparing for careers in pharmacology including teaching and research in an academic or industrial setting or in pharmaceutical companies and government research organizations.
Training in pharmacology equips a student with the ability to understand the molecular mechanisms of drugs, significance of correct dosage, efficacy and safety of medicines etc. and hence provide extensive employment opportunities by pharmaceutical industry and contract research organizations in various areas such as basic pharmacological research, toxicology, clinical pharmacology, scientific writing, regulatory, pharmacovigilance and medical marketing etc.
The department offers undergraduate (D. Pharm., and B. Pharm.), postgraduate (M.Pharm. in Pharmacology and Pharmacy Practice) and doctoral (Pharmacology, Pharmacology with specialization in Pharmacy Practice and Pharmaceutical Medicine) programmes.
The Pharmacy Practice programme is run in collaboration with Hakeem Abdul Hameed Centenary Hospital, Jamia Hamdard.
Ph.D. in Pharmaceutical Medicine is a unique, first in country program, established in collaboration with Ranbaxy Laboratories (now Sun Pharmaceuticals), illustrates utilization of academic excellence, professional expertise and optimal fund use by joint University-Industry effort.
Presently, the department has 08 faculty members with wide range of research interests:
- Neuropharmacology (Epilepsy, Alzheimer’s disease, Depression, Stroke, Schizophrenia, Cognition and Drug abuse),
- Cardiovascular pharmacology (Hypertension, Cardiomyopathy and Myocardial infarction)
- Endocrinology and others (Diabetes, Osteoporosis, Obesity)
- Clinical Pharmacology
Research activities within the Department of Pharmacology are well-funded by various agencies such as DST, ICMR, UGC, AICTE, CCRUM etc. In the last 5 years, department has received research grants worth Rs 2 crores from various funding agencies in India.
The department was sanctioned grants under Special Assistance Programme (SAP) of University Grants Commission (UGC), DRS Phase 1 and 2, on thrust area ‘Epilepsy and Osteoporosis’, UGC Major Research Grant on ‘Study of gut microbiota-induced atherosclerosis and obesity and modulation by Embelin in rats’ and ‘Evaluation of guggulipid extract in animal model of focal cerebral ischemia in rats’ and ICMR research grant on antiepileptic drugs associated osteoporosis.
The faculty members of the department have published >200 papers in national and International journals of repute in the last 5 years.
The department is well-equipped with instruments for research. Apart from other laboratories, the department has one specialized laboratory dedicated to research on neurobehavioral pharmacology. This laboratory is funded under assistance from UGC-SAP. The thrust area of the laboratory is to screen molecules for effects on the central nervous system and to investigate the pathophysiological basis of neurological diseases particularly epilepsy and epilepsy-associated problems and other neurodegenerative disorders.
Overall, there is a strong research culture in the department with an emphasis on quality of publications, Ph.D. theses and research projects.
Interdisciplinary collaboration is a key to successful research. This is true for Pharmacology, which as a discipline, has undergone tremendous change. Today, we combine the approaches of molecular biology, biotechnology and genetics etc. to study the pharmacodynamic basis of drug action. At Jamia Hamdard, there is an added advantage of having such collaborations within the various departments of the University. This is true even within SPER. For instance, the molecules synthesized in the Pharmaceutical Chemistry or the herbal extracts from Pharmacognosy Department or the developed formulations by the Department of Pharmaceutics are evaluated in Department of Pharmacology. The department also has collaborations outside the University both from academic and research institutions as well as pharmaceutical industry.